WS #13304
Holding: newest synthesis is 100d 12h old
Reported early merger talks between AstraZeneca and BMS could create a £300bn pharma giant, subject to regulatory hurdles.
AstraZeneca-Bristol Myers Squibb merger talks
Reported early merger talks between AstraZeneca and BMS could create a £300bn pharma giant, subject to regulatory hurdles.